Traws Pharma, Inc. — Director's Dealing 2017

Apr 28, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2017-04-26

Reporting Person: Kumar Ramesh (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-26	Common Stock	P	23810	$2.10	Acquired	102227	Direct

Footnotes

F1: 37,510 shares are held by the Ramesh Kumar 2012 Trust, of which the reporting person is a trustee.